Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Ferroptosis inducer 24 is an inducer of ferroptosis.1 It inhibits glutathione peroxidase 4 (GPX4) by 30-35% when used at a concentration of 50 µM. Ferroptosis inducer 24 (10 µM) increases the levels of heme oxygenase-1 (HO-1) in MDA-MB-231 triple-negative breast cancer cells, as well as increases the levels of bilirubin formed by HO-1 in MDA-MB-231 cell lysates. It reduces the viability of, as well as increases the levels of oxidized lipids, decreases the levels of IL-6 and glutathione (GST), and disrupts the mitochondrial membrane potential in, MDA-MB-231 cancer cells when used at a concentration of 50 µM. Ferroptosis inducer 24 also increases the levels of reactive oxygen species (ROS) in a time-dependent manner.
WARNING This product is not for human or veterinary use.
1. Synthesis and in vitro evaluation of CAPE derivatives as ferroptosis inducers in triple negative breast cancer. ACS Med. Chem. Lett. 15(5), 706-713 (2024).